Home/Filings/4/0000899243-21-036577
4//SEC Filing

Melian Agustin 4

Accession 0000899243-21-036577

CIK 0001754068other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:05 PM ET

Size

10.1 KB

Accession

0000899243-21-036577

Insider Transaction Report

Form 4
Period: 2021-04-05
Melian Agustin
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-04-05$23.89/sh18,212$435,085498,304 total
  • Sale

    Common Stock

    2021-09-15$24.03/sh800$19,224478,918 total
  • Sale

    Common Stock

    2021-07-02$19.99/sh18,586$371,534479,718 total
  • Sale

    Common Stock

    2021-09-17$24.01/sh2,950$70,842475,968 total
Footnotes (3)
  • [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
  • [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Issuer

Allovir, Inc.

CIK 0001754068

Entity typeother

Related Parties

1
  • filerCIK 0001818064

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:05 PM ET
Size
10.1 KB